|
WO2021078988A1
|
|
Recombinant l-asparaginase
|
|
US10940133B1
|
|
Methods of providing solriamfetol therapy to subjects with impaired renal function
|
|
WO2020118165A1
|
|
Subcutaneous delivery of high concentration formulations
|
|
WO2020106735A1
|
|
Alcohol-resistant drug formulations
|
|
BR112020010976A2
|
|
asparaginase treatment methods
|
|
TW201909904A
|
|
High concentration formulations
|
|
CN111094238A
|
|
Carbamoyl phenylalaninol analogs and uses thereof
|
|
EP3642340A1
|
|
Modified l-asparaginase
|
|
KR20200016889A
|
|
Methods and compositions for treating excessive sleepiness
|
|
US2018263936A1
|
|
Gamma-hydroxybutyrate compositions and their use for the treatment of disorders
|
|
US2014249115A1
|
|
Method of administration of gamma hydroxybutyrate with monocarboxylate transporters
|
